Lenograstim

Jump to: navigation, search
Lenograstim
Clinical data
ATC code
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Lenograstim

Articles

Most recent articles on Lenograstim

Most cited articles on Lenograstim

Review articles on Lenograstim

Articles on Lenograstim in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lenograstim

Images of Lenograstim

Photos of Lenograstim

Podcasts & MP3s on Lenograstim

Videos on Lenograstim

Evidence Based Medicine

Cochrane Collaboration on Lenograstim

Bandolier on Lenograstim

TRIP on Lenograstim

Clinical Trials

Ongoing Trials on Lenograstim at Clinical Trials.gov

Trial results on Lenograstim

Clinical Trials on Lenograstim at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lenograstim

NICE Guidance on Lenograstim

NHS PRODIGY Guidance

FDA on Lenograstim

CDC on Lenograstim

Books

Books on Lenograstim

News

Lenograstim in the news

Be alerted to news on Lenograstim

News trends on Lenograstim

Commentary

Blogs on Lenograstim

Definitions

Definitions of Lenograstim

Patient Resources / Community

Patient resources on Lenograstim

Discussion groups on Lenograstim

Patient Handouts on Lenograstim

Directions to Hospitals Treating Lenograstim

Risk calculators and risk factors for Lenograstim

Healthcare Provider Resources

Symptoms of Lenograstim

Causes & Risk Factors for Lenograstim

Diagnostic studies for Lenograstim

Treatment of Lenograstim

Continuing Medical Education (CME)

CME Programs on Lenograstim

International

Lenograstim en Espanol

Lenograstim en Francais

Business

Lenograstim in the Marketplace

Patents on Lenograstim

Experimental / Informatics

List of terms related to Lenograstim

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as a immunostimulator.[1]

References

  1. Amadori S, Suciu S, Jehn U; et al. (2005). "Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study". Blood. 106 (1): 27–34. doi:10.1182/blood-2004-09-3728. PMID 15761020.



Linked-in.jpg